Jump to navigation Jump to search

Chemical name 4-chloro-2,5-Dimethoxy-amphetamine or
Chemical formula C11H16NO2
Molar mass 229.70628
266.16692 (hydrochloride salt)
Melting point 187-188 °C and 193-194.5 (hydrochloride)
CAS numbers ?
SMILES COc1cc(C[C@@H](C)N)c(cc1Cl)OC

WikiDoc Resources for 4-Chloro-2,5-dimethoxyamphetamine


Most recent articles on 4-Chloro-2,5-dimethoxyamphetamine

Most cited articles on 4-Chloro-2,5-dimethoxyamphetamine

Review articles on 4-Chloro-2,5-dimethoxyamphetamine

Articles on 4-Chloro-2,5-dimethoxyamphetamine in N Eng J Med, Lancet, BMJ


Powerpoint slides on 4-Chloro-2,5-dimethoxyamphetamine

Images of 4-Chloro-2,5-dimethoxyamphetamine

Photos of 4-Chloro-2,5-dimethoxyamphetamine

Podcasts & MP3s on 4-Chloro-2,5-dimethoxyamphetamine

Videos on 4-Chloro-2,5-dimethoxyamphetamine

Evidence Based Medicine

Cochrane Collaboration on 4-Chloro-2,5-dimethoxyamphetamine

Bandolier on 4-Chloro-2,5-dimethoxyamphetamine

TRIP on 4-Chloro-2,5-dimethoxyamphetamine

Clinical Trials

Ongoing Trials on 4-Chloro-2,5-dimethoxyamphetamine at Clinical Trials.gov

Trial results on 4-Chloro-2,5-dimethoxyamphetamine

Clinical Trials on 4-Chloro-2,5-dimethoxyamphetamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 4-Chloro-2,5-dimethoxyamphetamine

NICE Guidance on 4-Chloro-2,5-dimethoxyamphetamine


FDA on 4-Chloro-2,5-dimethoxyamphetamine

CDC on 4-Chloro-2,5-dimethoxyamphetamine


Books on 4-Chloro-2,5-dimethoxyamphetamine


4-Chloro-2,5-dimethoxyamphetamine in the news

Be alerted to news on 4-Chloro-2,5-dimethoxyamphetamine

News trends on 4-Chloro-2,5-dimethoxyamphetamine


Blogs on 4-Chloro-2,5-dimethoxyamphetamine


Definitions of 4-Chloro-2,5-dimethoxyamphetamine

Patient Resources / Community

Patient resources on 4-Chloro-2,5-dimethoxyamphetamine

Discussion groups on 4-Chloro-2,5-dimethoxyamphetamine

Patient Handouts on 4-Chloro-2,5-dimethoxyamphetamine

Directions to Hospitals Treating 4-Chloro-2,5-dimethoxyamphetamine

Risk calculators and risk factors for 4-Chloro-2,5-dimethoxyamphetamine

Healthcare Provider Resources

Symptoms of 4-Chloro-2,5-dimethoxyamphetamine

Causes & Risk Factors for 4-Chloro-2,5-dimethoxyamphetamine

Diagnostic studies for 4-Chloro-2,5-dimethoxyamphetamine

Treatment of 4-Chloro-2,5-dimethoxyamphetamine

Continuing Medical Education (CME)

CME Programs on 4-Chloro-2,5-dimethoxyamphetamine


4-Chloro-2,5-dimethoxyamphetamine en Espanol

4-Chloro-2,5-dimethoxyamphetamine en Francais


4-Chloro-2,5-dimethoxyamphetamine in the Marketplace

Patents on 4-Chloro-2,5-dimethoxyamphetamine

Experimental / Informatics

List of terms related to 4-Chloro-2,5-dimethoxyamphetamine


4-Chloro-2,5-dimethoxyamphetamine or 2,5-dimethoxy-4-chloroamphetamine or 4-Chloro-2,5-DMA or DOC is a psychedelic hallucinogenic drug of the phenethylamine family. Used by some as an entheogen, DOC was presumably first synthesized by Alexander Shulgin. The drug is generally taken orally, but some users have been known to insufflate or smoke the pure powder.


DOC is a substituted alpha-methylated phenethylamine, a class of compounds commonly known as amphetamines. The full name of the chemical is 2,5-dimethoxy-4-chloro-amphetamine. DOC has a stereocenter and R-(-)-DOC is the more active stereoisomer. DOC is the 3-carbon chain homologue of the psychedelic 2C-C.


A normal average dose of DOC ranges from .5-8.0 mg; the former producing threshold effects, and the latter producing extremely strong effects. Doses up to 10mg have been known to send the user into a restless stupor. Onset of the drug is 1-3 hours, peak and plateau at 4-8 hours, and a gradual come down. After effects can last well into the next day.


Unlike simple amphetamines, DOC is a psychedelic that resembles LSD, DOB, and mescaline. These effects include open and closed eye visuals, increased awareness of sound and movement and euphoria.


The mechanism of DOC’s hallucinogenic effects is unknown, but like DOB and DOI, it may be mediated by partial agonistic activity at the 5-HT2A serotonin receptor, and binding affinity for the 5-HT2B and the 5-HT2C serotonin receptor.


The toxicity of DOC is not known, but nausea, chest pains, and vasoconstriction have been reported by some users. In June 2006 four teenagers were admitted to a hospital in Metropolitan Detroit, Michigan after accidentally overdosing DOC.[1] To date, there have been no deaths attributed to DOC. However, DOC is an extremely potent psychoactive, and the risk of overdose is great if unknown or extreme dosages are taken.


Although rare on the black market, sales of DOC on blotting paper and in capsules was reported in late 2005. DOC is sometimes misrepresented as LSD by unscrupulous dealers. This is particularly dangerous, as DOC is not known to have the safety profile of LSD.


4-chloro-2,5-dimethoxyamphetamine is unscheduled in the United States. It is likely that it would be considered an analogue (of DOB or DOM), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. In the United States, the analogues 2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxyamphetamine, and 4-methyl-2,5-dimethoxyamphetamine are Schedule I controlled substances. DOC is scheduled in many other countries including Canada, Germany, New Zealand, Sweden and the UK.

See also

External links


Template:Hallucinogenic phenethylamines Template:PiHKAL

Template:WikiDoc Sources